OncLive® On Air

OncLive® On Air
OncLive® On Air

In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers, hematologic malignancies, gynecologic cancers, genitourinary cancers, and more.

  1. 5시간 전

    Asciminib and Ponatinib Sit at the Forefront of Advances in CML Management: Insights From Onyee Chan, MD; and Bradley D. Hunter, MD

    In our exclusive interview, Drs Chan and Hunter discussed the integration of asciminib (Scemblix) as a first-line therapy for patients with CML, optimal treatment sequencing in CML management, and how findings from the phase 2 OPTIC trial (NCT02467270) have influenced ponatinib (Iclusig) dosing strategies in patients with chronic-phase disease. They also addressed the role of mutational testing in guiding treatment selection, strategies to mitigate adverse effects, and the evolving role of stem cell transplantation in the treatment paradigm.

    14분
  2. Explore MRD Dynamics With Isa-VRd in Newly Diagnosed Multiple Myeloma: Insights From Philippe Moreau, MD

    6시간 전

    Explore MRD Dynamics With Isa-VRd in Newly Diagnosed Multiple Myeloma: Insights From Philippe Moreau, MD

    In our exclusive interview, Dr Moreau discussed key findings from an analysis of minimal residual disease negativity dynamics from IMROZ and the potential future implications of these findings for patients with newly diagnosed multiple myeloma who receive treatment with Isa-VRd.

    8분
  3. Zanubrutinib Leads the Way for Advancements in CLL Management: With Mazyar Shadman, MD, MPH

    4일 전

    Zanubrutinib Leads the Way for Advancements in CLL Management: With Mazyar Shadman, MD, MPH

    Dr Shadman discusses key findings and implications from trials that were presented at the 2024 ASH Annual Meeting investigating zanubrutinib in CLL.

    15분
  4. Unpacking Key Data From the 2024 ASH Annual Meeting: With Andre Goy, MD

    5일 전

    Unpacking Key Data From the 2024 ASH Annual Meeting: With Andre Goy, MD

    Andre Goy, MD, discusses top hematologic oncology research from the 2024 ASH Annual Meeting.

    23분
  5. Exploring Lasofoxifene Plus Abemaciclib in ESR1+ Breast Cancer: Insights from ELAINE-3 With Sagar D. Sardesai, MBBS

    12월 16일

    Exploring Lasofoxifene Plus Abemaciclib in ESR1+ Breast Cancer: Insights from ELAINE-3 With Sagar D. Sardesai, MBBS

    Sagar D. Sardesai, MBBS, discusses the phase 3 ELAINE-3 trial evaluating lasofoxifene plus abemaciclib in ESR1-mutant, ER+/HER2- metastatic breast cancer.

    5분
  6. Explore Findings With Nivolumab Plus AVD in Advanced-Stage Classic Hodgkin Lymphoma: With Alex F. Herrera, MD

    12월 13일

    Explore Findings With Nivolumab Plus AVD in Advanced-Stage Classic Hodgkin Lymphoma: With Alex F. Herrera, MD

    Dr Herrera explains why N+AVD is a strong candidate for primary treatment in adolescent and adult patients with stage III or IV Hodgkin lymphoma.

    15분
  7. Delve Into Data With Amivantamab Plus Lazertinib in EGFR-Mutated NSCLC: With Chandler Park, MD; and Stephen Liu, MD

    12월 12일

    Delve Into Data With Amivantamab Plus Lazertinib in EGFR-Mutated NSCLC: With Chandler Park, MD; and Stephen Liu, MD

    Drs Park and Liu discuss the use of amivantamab plus lazertinib in EGFR-mutated non–small cell lung cancer.

    17분
  8. T-DXd Steadily Transforms the NSCLC Treatment Paradigm: With Misako Nagasaka, MD, PhD

    12월 10일

    T-DXd Steadily Transforms the NSCLC Treatment Paradigm: With Misako Nagasaka, MD, PhD

    Dr Nagasaka discusses the use of T-DXd in patients with unresectable or metastatic HER2-positive NSCLC.

    10분
모두 보기(500개)

평가 및 리뷰

4.2
최고 5점
21개의 평가

소개

In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers, hematologic malignancies, gynecologic cancers, genitourinary cancers, and more.

정보

  • 제작진
    OncLive® On Air
  • 방송 연도
    2018년 - 2024년
  • 에피소드
    500
  • 등급
    전체 연령 사용가
  • 웹사이트 보기
    OncLive® On Air

좋아할 만한 다른 항목

  • Two Onc Docs
    의학
    의학

    매주 업데이트

  • NEJM This Week
    의학
    의학

    매주 업데이트

  • Oncology Today with Dr Neil Love
    의학
    의학

    매주 업데이트

  • JAMA Editors' Summary
    의학
    의학

    매주 업데이트

  • PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast
    과학
    과학

    12월 12일

  • Research To Practice | Oncology Videos
    과학
    과학

    매주 업데이트

  • ASCO Daily News
    의학
    의학

    격주 업데이트

무삭제판 에피소드를 청취하려면 로그인하십시오.

이 프로그램의 최신 정보 받기

프로그램을 팔로우하고, 에피소드를 저장하고, 최신 소식을 받아보려면 로그인하거나 가입하십시오.
국가 또는 지역 선택

아프리카, 중동 및 인도

아시아 태평양

유럽

라틴 아메리카 및 카리브해

미국 및 캐나다